Beta: Sign in
Shares outstandingAs of 2026-09-17 · filed common shares: 5.41M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 1.19%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 23.50%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 23.60%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginFY Jun 26: -1401.09%
Net margin: —
EBITDA marginFY Jun 26: -1344.62%
Return on equityNet income (FY Jun 26) ÷ average shareholders equity: -61.70%
Return on assetsNet income (FY Jun 26) ÷ average total assets: -46.95%

Growth

Revenue growth (annual YoY): -92.50%
Revenue growth (latest qtr YoY): —
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): -104.48%
EPS growth (fwd): Sign in
Net income growth (QoQ): -127.09%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Jun 26

-3.06

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $19.86M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Mar 26: $0
Debt / equityas of Mar 26: 0.00%
Current ratioas of Jun 26: 27.85
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 27.33
Operating cash flowFY Jun 26: -$12.35M
Free cash flow: —
TTM revenue / diluted shareDiluted, FY Jun 26: 0.27

NEUP stock Statistics — Neuphoria Therapeutics Inc. filings, insiders & smart money · Instaport